Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Shy

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Neurology|January 30, 2008
Neuropathy progression in Charcot-Marie-Tooth disease type 1AM E Shy, L Chen, E R Swan, et al.
Brain : a Journal of Neurology|June 27, 2000
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1AK M Krajewski, R A Lewis, D R Fuerst, et al.
Brain : a Journal of Neurology|January 29, 2000
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapyJ Kamholz, D Menichella, A Jani, et al.
Neurology|April 22, 2011
MFN2 mutations cause severe phenotypes in most patients with CMT2AS M E Feely, M Laura, C E Siskind, et al.
Neurology|April 13, 2005
Reliability and validity of the CMT neuropathy score as a measure of disabilityM E Shy, J Blake, K Krajewski, et al.
Neurology|May 1, 1988
Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron diseaseN Latov, A P Hays, P D Donofrio, et al.
Neurology|November 1, 1986
Motor neuron disease and plasma cell dyscrasiaM E Shy, L P Rowland, T Smith, et al.
Journal of Neurology|July 7, 2019
Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotypeIlaria Callegari, C Gemelli, A Geroldi, et al.
Journal of Neurobiology|July 6, 2000
Proteolipid protein mRNA stability is regulated by axonal contact in the rodent peripheral nervous systemH Jiang, C S Duchala, R Awatramani, et al.
Annals of Neurology|May 1, 1989
Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasiaM E Shy, V A Evans, F D Lublin, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Neurology|January 30, 2008
Neuropathy progression in Charcot-Marie-Tooth disease type 1AM E Shy, L Chen, E R Swan, et al.
Brain : a Journal of Neurology|June 27, 2000
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1AK M Krajewski, R A Lewis, D R Fuerst, et al.
Brain : a Journal of Neurology|January 29, 2000
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapyJ Kamholz, D Menichella, A Jani, et al.
Neurology|April 22, 2011
MFN2 mutations cause severe phenotypes in most patients with CMT2AS M E Feely, M Laura, C E Siskind, et al.
Neurology|April 13, 2005
Reliability and validity of the CMT neuropathy score as a measure of disabilityM E Shy, J Blake, K Krajewski, et al.
Neurology|May 1, 1988
Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron diseaseN Latov, A P Hays, P D Donofrio, et al.
Neurology|November 1, 1986
Motor neuron disease and plasma cell dyscrasiaM E Shy, L P Rowland, T Smith, et al.
Journal of Neurology|July 7, 2019
Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotypeIlaria Callegari, C Gemelli, A Geroldi, et al.
Journal of Neurobiology|July 6, 2000
Proteolipid protein mRNA stability is regulated by axonal contact in the rodent peripheral nervous systemH Jiang, C S Duchala, R Awatramani, et al.
Annals of Neurology|May 1, 1989
Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasiaM E Shy, V A Evans, F D Lublin, et al.
Pageof 5